Business Context and Reporting Period
The supplied filing is Colfax Corporation’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2016; it does not identify Enovis Corporation. Investors should verify the company identity and filing mapping. Colfax operated through Gas and Fluid Handling and Fabrication Technology, providing industrial gas-handling, fluid-handling, welding and cutting products globally.
Approximately 75% of third-quarter sales and 72% of nine-month sales came from operations outside the United States. Results are subject to seasonality, including typically stronger gas- and fluid-handling shipments in the fourth quarter.
Financial Performance and Position
| Metric | Q3 2016 | Q3 2015 | 9M 2016 | 9M 2015 |
|---|---|---|---|---|
| Net sales | $879.2 million | $969.1 million | $2,713.3 million | $2,905.6 million |
| Gross profit | $275.4 million | $295.9 million | $857.0 million | $918.3 million |
| Gross margin | 31.3% | 30.5% | 31.6% | 31.6% |
| Operating income | $50.5 million | $45.6 million | $172.0 million | $219.6 million |
| Net income attributable to Colfax | $28.0 million | $18.4 million | $90.3 million | $123.5 million |
| Diluted EPS | $0.23 | $0.15 | $0.73 | $0.99 |
| Interest expense | $6.8 million | $10.9 million | $24.6 million | $37.2 million |
Q3 operating margin was 5.7%, compared with 4.7% in the prior-year quarter. Nine-month operating margin was 6.3%, compared with 7.6% in the prior-year period. Segment operating income, before restructuring charges, was $67.7 million in Q3 and $221.4 million for nine months.
- Gas and Fluid Handling: Q3 sales were $433.1 million, down from $481.9 million; segment operating margin increased to 6.8% from 5.5%. Nine-month sales were $1,349.6 million and segment margin was 8.0%, down from 9.0%.
- Fabrication Technology: Q3 sales were $446.1 million, down from $487.2 million; segment operating margin increased to 10.8% from 8.7%. Nine-month sales were $1,363.7 million and segment margin was 10.9%, up from 10.3%.
- Cash provided by operations was $101.9 million for nine months, down from $152.1 million. Capital expenditures were $41.7 million, and investing cash use was $41.7 million because no acquisition cash payments occurred in 2016 versus $184.5 million in 2015.
- Cash and cash equivalents were $191.7 million at September 30, 2016, compared with $197.5 million at December 31, 2015. Cash declined $5.8 million during the nine months.
- Total debt was $1.385 billion, including $1.379 billion of long-term debt. The weighted-average interest rate under the Credit Agreement was 1.92%; $779.4 million remained available under the revolving credit facility.
- Letters of credit totaled $352.5 million against total capacity of $756.8 million. Receivables-financing borrowings were $76.6 million at a 1.39% interest rate.
- The company was in compliance with its credit agreement covenants. Management stated that available liquidity was adequate for the next twelve months.
Material Changes Versus the Prior Comparable Period
- Q3 sales declined 9.3%; nine-month sales declined 6.6%. Existing-business sales fell $65.9 million in Q3 and $125.6 million for nine months, while foreign exchange reduced sales by $25.3 million and $118.3 million, respectively.
- Lower volumes affected power generation, general industrial, marine and other markets. Gas and fluid handling orders increased in Q3, but nine-month orders declined; backlog fell 15.7% to $1.108 billion.
- Gross profit declined in absolute dollars, but Q3 gross margin improved because of cost controls and fabrication-technology savings. Gas and fluid handling margins were pressured by lower volumes, foreign exchange, inventory charges and higher warranty and contract-loss provisions.
- SG&A declined $37.7 million in Q3 and $45.7 million for nine months, principally from cost reductions, restructuring savings and foreign exchange benefits.
- Restructuring charges increased to $17.2 million in Q3 and $49.3 million for nine months, versus $13.1 million and $25.7 million, respectively. Management expected approximately $20 million of additional restructuring charges during the remainder of 2016.
- Interest expense decreased materially because of refinancing-related lower non-cash interest, lower foreign-currency charges and interest income on a tax refund.
- The nine-month 2015 tax provision included a $13.0 million benefit from resolving uncertain tax liabilities; this benefit did not recur in 2016, contributing to the higher 2016 nine-month effective tax rate of 30.6% versus 24.0%.
- The company repurchased 1.0 million shares for approximately $20.8 million during the first nine months. Approximately $52 million remained under the authorization at September 30, 2016.
Guidance, Outlook, Commentary, Risks and Unusual Items
- No specific revenue or earnings guidance is provided in the supplied filing. Management cited challenging cyclical economic conditions and continued cost-reduction programs.
- Foreign exchange reduced Q3 and nine-month income before taxes by approximately 7% and 6%, respectively. A 10% depreciation in major currencies would have reduced equity by approximately $250 million, net of the euro-denominated debt hedge.
- Venezuelan operations were deconsolidated because government restrictions impaired exchangeability, payments and management control. The resulting charge was $2.4 million; the Venezuelan operations represented less than 1% of net assets, revenue and operating income.
- A Delaware Supreme Court ruling reduced the net recoverable asbestos-insurance asset by $8.2 million. The ruling is also expected to generate approximately $88 million of insurer reimbursements for previously funded defense and settlement costs, although timing is uncertain.
- Other asbestos estimates produced a $1.9 million net charge. At September 30, 2016, asbestos liabilities totaled approximately $392.7 million and related insurance assets and receivables totaled approximately $411.6 million.
- There were 21,513 unresolved asbestos claims at September 30, 2016. Actual liabilities and recoveries may differ materially because of claim volumes, settlement costs, insurance coverage, insurer solvency and litigation outcomes.
- The company faced patent-infringement litigation brought by Lincoln Electric, but management did not expect a material adverse effect. The filing states that adverse outcomes across legal proceedings could nevertheless materially affect results.
- Key risks include economic and commodity-price cycles, customer capital spending, foreign exchange, raw-material costs, restructuring execution, acquisitions, pension funding, product liability, cybersecurity, regulatory compliance, intellectual property and debt-covenant restrictions.
Important Facts for Investors to Verify
- Confirm whether this Colfax Corporation filing is the intended source for the requested Enovis Corporation 2016 Q3 summary.
- Verify the sustainability of earnings improvement despite declining sales, lower nine-month operating margin and substantial restructuring activity.
- Assess liquidity after considering $1.385 billion of debt, variable-rate exposure, letter-of-credit commitments and the December 20, 2016 scheduled termination of the $80 million receivables facility.
- Review asbestos liability and insurance-recovery assumptions, including the uncertain timing of the expected $88 million reimbursement.
- Evaluate the impact of foreign exchange, international cash restrictions and the $250 million equity sensitivity disclosed for a 10% currency depreciation.
- Confirm the expected $20 million of additional 2016 restructuring charges and whether anticipated savings offset those costs.
- Review backlog trends, end-market exposure and the absence of explicit full-year financial guidance.